Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chiniara Ellen
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Esposito Pamela
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Atlas Venture Fund X, L.P.(6.4%),Atlas Venture Associates X, L.P.(6.4%), etc.
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.3%)
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)
Kymera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(7.933%),Abigail P. Johnson(7.933%)
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(7.17%),Wellington Group Holdings LLP(7.17%), etc.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Esposito Pamela
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BVF PARTNERS L P/IL
Kymera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.3%),Baker Bros. Advisors (GP) LLC(9.3%), etc.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gollob Jared
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Booth Bruce
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BVF PARTNERS L P/IL
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sandor Victor